These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 31189582)

  • 1. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of
    Tam KK; Leung KS; Siu GK; Chang KC; Wong SS; Ho PL; Leung EK; Yam WC
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
    Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W
    Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.
    Maslov DA; Zaĭchikova MV; Chernousova LN; Shur KV; Bekker OB; Smirnova TG; Larionova EE; Andreevskaya SN; Zhang Y; Danilenko VN
    Tuberculosis (Edinb); 2015 Sep; 95(5):608-12. PubMed ID: 26071666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-
    Werngren J; Alm E; Mansjö M
    J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
    Jonmalung J; Prammananan T; Leechawengwongs M; Chaiprasert A
    BMC Microbiol; 2010 Aug; 10():223. PubMed ID: 20727143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
    Bwalya P; Yamaguchi T; Mulundu G; Nakajima C; Mbulo G; Solo ES; Fukushima Y; Kasakwa K; Suzuki Y
    Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
    BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazinamide Susceptibility and
    Rahman A; Ferdous SS; Ahmed S; Rahman SMM; Uddin MKM; Pholwat S; Gratz J; Houpt E; Banu S
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
    Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y
    BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
    Che Y; Bo D; Lin X; Chen T; He T; Lin Y
    BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of pncA, rpsA and panD Gene Mutations Associated with Resistance in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates and Spoligotyping].
    Özgür D; Tezcan Ülger S; Kayar MB; Biçmen C; Aslantürk A; Ülger M; Aslan G
    Mikrobiyol Bul; 2022 Apr; 56(2):191-205. PubMed ID: 35477224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.
    Sengstake S; Bergval IL; Schuitema AR; de Beer JL; Phelan J; de Zwaan R; Clark TG; van Soolingen D; Anthony RM
    BMC Infect Dis; 2017 Jul; 17(1):491. PubMed ID: 28697808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspects.
    Wu X; Lu W; Shao Y; Song H; Li G; Li Y; Zhu L; Chen C
    Infect Genet Evol; 2019 Aug; 72():147-150. PubMed ID: 30447296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations.
    Gu Y; Yu X; Jiang G; Wang X; Ma Y; Li Y; Huang H
    Diagn Microbiol Infect Dis; 2016 Mar; 84(3):207-11. PubMed ID: 26775806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
    Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH
    Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
    Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y
    Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is sequencing better than phenotypic tests for the detection of pyrazinamide resistance?
    Bouzouita I; Cabibbe AM; Trovato A; Draoui H; Ghariani A; Midouni B; Essalah L; Mehiri E; Cirillo DM; Slim-Saidi L
    Int J Tuberc Lung Dis; 2018 Jun; 22(6):661-666. PubMed ID: 29862951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.
    Maningi NE; Daum LT; Rodriguez JD; Mphahlele M; Peters RP; Fischer GW; Chambers JP; Fourie PB
    J Clin Microbiol; 2015 Dec; 53(12):3779-83. PubMed ID: 26378284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.
    Werngren J; Sturegård E; Juréen P; Ängeby K; Hoffner S; Schön T
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1253-7. PubMed ID: 22203587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda.
    Naluyange R; Mboowa G; Komakech K; Semugenze D; Kateete DP; Ssengooba W
    PLoS One; 2020; 15(5):e0232543. PubMed ID: 32413052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.